Nemea Therapeutics, Inc.
PrivateLast Round
Seed
Apr 1, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nemea Therapeutics, Inc. is a biotechnology company developing oral small molecule inhibitors targeting mitochondrial RNA polymerase for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nemea Therapeutics, Inc. Comparables
Compare Nemea Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imel Biotherapeutics | 77% | |
| Talus Bio | 77% | |
| KyDo Therapeutics | 75% |
Nemea Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2026 | ||||
| Pre Seed | Nov 1, 2025 |
Nemea Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHAN Technology Transfer Fund II | Pre Seed |
| MATWIN | Accelerator |
| BCM Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$25M raised in Seed round.
- Nov 1, 2025
$2M raised from BCM Ventures and KHAN Technology Transfer Fund II.
Nemea Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nemea Therapeutics, Inc.'s valuation, stock price, and market status.
Is Nemea Therapeutics, Inc. a public or private company?
Nemea Therapeutics, Inc. is a private company.
What is the current stock price of Nemea Therapeutics, Inc.?
Nemea Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Nemea Therapeutics, Inc. worth (valuation)?
Valuation information for Nemea Therapeutics, Inc. is not publicly available.
Can I buy Nemea Therapeutics, Inc. stock?
Nemea Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nemea Therapeutics, Inc.'s last funding round?
Nemea Therapeutics, Inc.'s most recent funding round was Pre Seed on April 1, 2026.
Who are the main investors in Nemea Therapeutics, Inc.?
Key investors in Nemea Therapeutics, Inc. include BCM Ventures.
Will Nemea Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Nemea Therapeutics, Inc..
How can I track Nemea Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nemea Therapeutics, Inc.'s secondary market activity and sign up for updates.